The science of consciousness
Through the MIT Consciousness Club, professors Matthias Michel and Earl Miller are exploring how neurological activity gives rise to human experience.
Particles that enhance mRNA delivery could reduce vaccine dosage and costs
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
MIT study finds targets for a new tuberculosis vaccine
Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.
New therapeutic brain implants could defy the need for surgery
MIT researchers created microscopic wireless electronic devices that travel through blood and implant in target brain regions, where they provide electrical stimulation.
A new patch could help to heal the heart
MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.
Designing better, longer-lasting medicines
Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.
Professor Ioannis Yannas, pioneer of regenerative medicine who invented artificial skin for the treatment of severe burns, dies at 90
A beloved member of the Department of Mechanical Engineering for nearly 60 years, Yannas helped save the lives of thousands of burn victims through his research and innovation.
Startup’s tablets deliver cancer drugs more evenly over time
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
MIT engineers solve the sticky-cell problem in bioreactors and other industries
Their system uses electrochemically generated bubbles to detach cells from surfaces, which could accelerate the growth of carbon-absorbing algae and lifesaving cell therapies.
Helping scientists run complex data analyses without writing code
Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.
AI maps how a new antibiotic targets gut bacteria
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
How federal research support has helped create life-changing medicines
A new study finds over half the drugs approved this century cite government-funded research in their patents.
New AI system could accelerate clinical research
By enabling rapid annotation of areas of interest in medical images, the tool can help scientists study new treatments or map disease progression.
New RNA tool to advance cancer and infectious disease research and treatment
Advance from SMART will help to better identify disease markers and develop targeted therapies and personalized treatment for diseases such as cancer and antibiotic-resistant infection.
Technology originating at MIT leads to approved bladder cancer treatment
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.